Mereo BioPharma Group Plc (MREO)
0.64
-0.03
(-4.55%)
USD |
NASDAQ |
Jan 16, 16:00
0.64
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Shareholders Equity (Annual): 60.97M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 10.42M |
| NuCana Plc | 7.457M |
| Autolus Therapeutics Plc | 427.32M |
| Bicycle Therapeutics Plc | 793.06M |
| Ultragenyx Pharmaceutical, Inc. | 255.30M |